179 related articles for article (PubMed ID: 30855445)
21. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
[TBL] [Abstract][Full Text] [Related]
23. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
24. Age is associated with prognosis in serous ovarian carcinoma.
Deng F; Xu X; Lv M; Ren B; Wang Y; Guo W; Feng J; Chen X
J Ovarian Res; 2017 Jun; 10(1):36. PubMed ID: 28606125
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Significance of Plakophilin-1 Expression in Esophageal Cancer.
Fujita J; Nakajima M; Muroi H; Kikuchi M; Ihara K; Yamaguchi T; Nakagawa M; Morita S; Nakamura T; Tsuchioka T; Kojima K
Anticancer Res; 2021 Jul; 41(7):3401-3407. PubMed ID: 34230135
[TBL] [Abstract][Full Text] [Related]
26. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
Davidson B; Trope' CG; Wang TL; Shih IeM
Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
[TBL] [Abstract][Full Text] [Related]
27. The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis.
Gao S; Zhang W; Yan N; Li M; Mu X; Yin H; Wang J
J Ovarian Res; 2021 Nov; 14(1):164. PubMed ID: 34789292
[TBL] [Abstract][Full Text] [Related]
28. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
29. Plakophilin 3 facilitates G1/S phase transition and enhances proliferation by capturing RB protein in the cytoplasm and promoting EGFR signaling.
Müller L; Keil R; Hatzfeld M
Cell Rep; 2023 Jan; 42(1):112031. PubMed ID: 36689330
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
Yu L; Deng L; Li J; Zhang Y; Hu L
Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
[TBL] [Abstract][Full Text] [Related]
31. Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Rossi E; Donzelli C; Todeschini P; Romani C; Bandiera E; Zanotti L; Carnazza M; Quadraro F; Tognon G; Sartori E; Pecorelli S; Roque DM; Santin AD
J Transl Med; 2013 Jul; 11():162. PubMed ID: 23819652
[TBL] [Abstract][Full Text] [Related]
32. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
[TBL] [Abstract][Full Text] [Related]
33. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
34. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
Takahashi H; Nakatsuji H; Takahashi M; Avirmed S; Fukawa T; Takemura M; Fukumori T; Kanayama H
Urology; 2012 Jan; 79(1):240.e1-8. PubMed ID: 22119253
[TBL] [Abstract][Full Text] [Related]
36. Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor.
Surowiak P; Materna V; Maciejczyk A; Pudelko M; Suchocki S; Kedzia W; Nowak-Markwitz E; Dumanska M; Spaczynski M; Zabel M; Dietel M; Lage H
Histol Histopathol; 2008 May; 23(5):531-8. PubMed ID: 18283637
[TBL] [Abstract][Full Text] [Related]
37. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
Sehouli J; Braicu EI; Richter R; Denkert C; Jank P; Jurmeister PS; Kunze CA; Budczies J; Darb-Esfahani S; Schmitt WD; Traut A; Grabowski J; Taube ET; Plett H
Hum Pathol; 2019 Mar; 85():299-308. PubMed ID: 30428389
[TBL] [Abstract][Full Text] [Related]
39. A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals.
Hong JY; Zapata J; Blackburn A; Baumert R; Bae SM; Ji H; Nam HJ; Miller RK; McCrea PD
Biochem Biophys Res Commun; 2021 Jul; 563():31-39. PubMed ID: 34058472
[TBL] [Abstract][Full Text] [Related]
40. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
